Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1961 1
1965 4
1966 9
1967 15
1968 10
1969 15
1970 15
1971 16
1972 12
1973 9
1974 12
1975 9
1976 12
1977 14
1978 12
1979 14
1980 18
1981 11
1982 16
1983 5
1984 25
1985 13
1986 20
1987 16
1988 19
1989 14
1990 21
1991 27
1992 31
1993 31
1994 25
1995 24
1996 20
1997 18
1998 20
1999 29
2000 38
2001 33
2002 47
2003 48
2004 48
2005 49
2006 74
2007 77
2008 100
2009 111
2010 161
2011 252
2012 296
2013 376
2014 385
2015 486
2016 480
2017 518
2018 556
2019 245
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

4,452 results
Results by year
Filters applied: . Clear all
Page 1
Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic).
Iasella CJ, et al. Clin Liver Dis 2017 - Review. PMID 27842776
Hepatotoxic adverse drug reactions are associated with significant morbidity and mortality and are the leading cause of postmarketing regulatory action in the United States. ...Type B are not clearly related to increasing dose and are associated with drug-specific and patient-specific characteristics and environmental risks. ...
Hepatotoxic adverse drug reactions are associated with significant morbidity and mortality and are the leading cause of …
The role of pharmacogenomics in adverse drug reactions.
Cacabelos R, et al. Expert Rev Clin Pharmacol 2019 - Review. PMID 30916581
Adverse drug reactions (ADRs) are a major health concern worldwide. There are multiple causes of ADRs, some of which are preventable. ...Areas covered: Important topics related to pharmacogenomics in drug efficacy and safety are covered, including: (i) major components of the pharmacogenomic machinery; (ii) epigenetic regulation of pharmagene expression; and (iii) pharmacogenomics-related ADRs of different drug categories. ...
Adverse drug reactions (ADRs) are a major health concern worldwide. There are multiple causes of ADRs, some of which ar
Adverse drug reactions: classification, susceptibility and reporting.
Kaufman G. Nurs Stand 2016. PMID 27507394
Adverse drug reactions (ADRs) are increasingly common and are a significant cause of morbidity and mortality. Historically, ADRs have been classified as type A or type B. Type A reactions are predictable from the known pharmacology of a drug and are associated with high morbidity and low mortality. ...
Adverse drug reactions (ADRs) are increasingly common and are a significant cause of morbidity and mortality. Historica
The extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia.
Roughead EE, et al. Int J Evid Based Healthc 2016 - Review. PMID 26886682
AIM: To provide an estimate of the numbers of medication errors and adverse drug reactions that occur along a person's journey through their hospital stay in Australia. ...Data on the rates of adverse drug reactions and medication errors associated with hospitalization was extracted from the published studies. ...
AIM: To provide an estimate of the numbers of medication errors and adverse drug reactions that occur along a person's …
Adverse drug reactions in hospitalized Colombian children.
de Las Salas R, et al. Colomb Med (Cali) 2016. PMID 27821893 Free PMC article.
INTRODUCTION: The occurrence of adverse drug reactions is an important issue due to the lack of drug safety data in children. ...RESULTS: Of a total of 772 monitored patients, 156 Adverse Drug Reactions were detected on 147 children. The cumulative incidence of Adverse Drug Reactions was 19.0% (147/772); the incidence density was 37.6 Adverse Drug Reactions per 1,000 patients-days (147/3,913). ...
INTRODUCTION: The occurrence of adverse drug reactions is an important issue due to the lack of drug safety data …
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Wastesson JW, et al. Expert Opin Drug Saf 2018 - Review. PMID 30540223
Caring for the growing number of older people with complex drug regimens and multimorbidity presents an important challenge in the coming years. ...
Caring for the growing number of older people with complex drug regimens and multimorbidity presents an important challenge in the co …
Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.
Aziz RK, et al. Expert Opin Drug Metab Toxicol 2018 - Review. PMID 30269615
Pharmacomicrobiomics and toxicomicrobiomics study how variations within the human microbiome (the combination of human-associated microbial communities and their genomes) affect drug disposition, action, and toxicity. ...Although the gut microbiota has been the most extensively studied, some key drug-microbiome interactions involve vaginal, intratumoral, and environmental bacteria, and are briefly discussed here. ...
Pharmacomicrobiomics and toxicomicrobiomics study how variations within the human microbiome (the combination of human-associated microbial …
Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: A systematic review of systematic reviews.
Wolfe D, et al. PLoS One 2018. PMID 30308067 Free PMC article.
BACKGROUND: Preventable adverse drug reactions (PADRs) in inpatients are associated with harm, including increased length of stay and potential loss of life, and result in elevated costs of care. ...Secondary review objectives were related to assessment of the effects of patient age, setting, and clinical specialty on PADR incidence. ...
BACKGROUND: Preventable adverse drug reactions (PADRs) in inpatients are associated with harm, including increased leng …
Effects of short-term fasting on cancer treatment.
de Groot S, et al. J Exp Clin Cancer Res 2019 - Review. PMID 31113478 Free PMC article.
This review focuses on the molecular background, current knowledge and clinical trials evaluating the effects of STF in cancer treatment. ...
This review focuses on the molecular background, current knowledge and clinical trials evaluating the effects of STF in cancer treatm …
Drug-induced liver injury: a safety review.
García-Cortés M, et al. Expert Opin Drug Saf 2018 - Review. PMID 30059261
INTRODUCTION: Idiosyncratic drug-induced liver injury (DILI) remains one of the most important causes of drug attrition both in the early phases of clinical drug development and in the postmarketing scenario. This is because, in spite of emerging data on genetic susceptibility variants associated to the risk of hepatotoxicity, the precise identification of the individual who will develop DILI when exposed to a given drug remains elusive. ...
INTRODUCTION: Idiosyncratic drug-induced liver injury (DILI) remains one of the most important causes of drug attrition both i …
4,452 results
Jump to page
Feedback